Linagliptin

For Research Use Only.
Category
Impurities
Cat.No.
NP2669
CAS
668270-12-0
Product Name
Linagliptin
Structure

Product Details

Description
Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
Synonyms
Tradjenta; BI-1356; BI 1356; BI1356; Ondero; Trajenta
IUPAC Name
8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
Molecular Weight
472.553
Molecular Formula
C25H28N8O2
Canonical SMILES
CC4=NC5=CC=CC=C5C(=N4)C)C
InChI
InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1
InChIKey
LTXREWYXXSTFRX-QGZVFWFLSA-N
Melting Point
190-196°C
Purity
98%
Appearance
White to yellow powder
Application
the treatment of type 2 diabetes
Form
Powder
Packaging
2.5 g
  • Verification code
Online Inquiry
  • Verification code
×
Top
Inquiry Basket